share_log

TherapeuticsMD And 2 Other Stocks Under $2 Executives Are Buying

TherapeuticsMD And 2 Other Stocks Under $2 Executives Are Buying

TherapeuticsMD和其他2只股票每股低於2美元,高管都在購買
Benzinga ·  2024/08/26 19:36

The Dow Jones index closed higher by more than 450 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

道瓊斯指數週五收盤上漲了450點以上。當內部人士購買或出售股票時,這表明他們對公司前景的信心或關切。對於對低價股感興趣的投資者和交易員,他們可以將這視爲其整體投資或交易決策的一個因素。

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

以下是幾個近期關於低價股的值得關注的內部交易。了解更多,請查看Benzinga內幕交易平台。

System1

System1

  • The Trade: System1, Inc. (NYSE:SST) 10% owner Cee Holdings Trust bought a total of 46,373 shares at an average price of $1.22. To acquire these shares, it cost around $56,378.
  • What's Happening: On Aug. 8, System1 posted upbeat quarterly earnings.
  • What System1 Does: System1 Inc develops technology and data science to operate a responsive acquisition marketing platform.
  • 交易:System1, Inc. (紐交所:SST) 10%持有人Cee Holdings Trust以平均價格1.22美元購入46373股。購入這些股票,成本約爲56378美元。
  • 正在發生什麼:8月8日,System1發佈了樂觀的季度收益報告。
  • System1 Inc開發技術和數據科學,以運營響應式收購營銷平台。

TherapeuticsMD

therapeuticsmd

  • The Trade: TherapeuticsMD, Inc. (NASDAQ:TXMD) Director Cooper C. Collins acquired a total of 1,200 shares at an average price of $1.70. To acquire these shares, it cost around $2,039.
  • What's Happening: On Aug. 12, TherapeuticsMD posted a second-quarter loss of 9 cents per share.
  • What TherapeuticsMD Does: TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories.
  • 交易:therapeuticsmd, Inc. (納斯達克:TXMD) 董事Cooper C. Collins以平均價格1.70美元獲得1200股。購入這些股票,成本約爲2039美元。
  • 最新動態:therapeuticsmd在8月12日公佈,每股虧損9美分。
  • therapeuticsmd的業務:therapeuticsmd公司是一家藥品特許權公司,目前正在從在相關領域具有商業能力的藥品機構許可的產品上獲取特許權。

Ault Alliance

奧特聯盟

  • The Trade: Ault Alliance, Inc. (NYSE:AULT) Executive Chairman Milton C Ault III acquired a total of 2,800 shares at an average price of $0.23. The insider spent around $655 to buy those shares.
  • What's Happening: On Aug. 20, Ault Alliance declared a monthly cash dividend of $0.2708333 Per Share of 13.00% Series D Cumulative Redeemable Perpetual Preferred Stock.
  • What Ault Alliance Does: Ault Alliance Inc is a diversified holding company. It operates a data center at which it mines Bitcoin and provides mission-critical products that support a diverse range of industries, including oil exploration, crane services, defense/aerospace, industrial, automotive, medical/biopharma, consumer electronics, hotel operations and textiles.
  • 交易:Ault Alliance, Inc.(NYSE:AULT)執行主席Milton C Ault III以0.23美元的平均價購入2800股,花費大約655美元購買了這些股票。
  • 最新動態:8月20日,Ault Alliance宣佈每股13.00%D系列可贖回永續優先股的月度現金股息爲0.2708333美元。
  • Ault Alliance的業務:Ault Alliance Inc是一家多元化控股公司。其在一個數據中心運營,用於挖掘比特幣,並提供支持多個行業的關鍵產品,包括石油勘探、起重服務、軍工/航空航天、工業、汽車、醫療/生物製藥、消費電子、酒店運營和紡織品。
  • Jim Cramer Praises L3Harris Technologies, Says Intel Is 'Getting Whacked' By AMD: 'I Much Prefer...'
  • 吉姆·克雷默讚揚L3Harris Technologies,並表示英特爾(Intel)正受到AMD的打擊:'我更喜歡……'
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論